Jiangsu Hengrui Pharmaceuticals Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2026 is -10.14% vs -3.56% in Mar 2026",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2026 is -4.24% vs 16.57% in Mar 2026",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'26",
        "Mar'26",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "7,315.00",
          "val2": "8,140.60",
          "chgp": "-10.14%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,865.30",
          "val2": "2,763.60",
          "chgp": "-32.50%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "2.60",
          "val2": "0.40",
          "chgp": "550.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "714.20",
          "val2": "129.10",
          "chgp": "453.21%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "2,184.30",
          "val2": "2,281.00",
          "chgp": "-4.24%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "218.40%",
          "val2": "306.60%",
          "chgp": "-8.82%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 13.11% vs 22.70% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 21.78% vs 48.14% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "31,431.00",
          "val2": "27,787.80",
          "chgp": "13.11%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "8,961.00",
          "val2": "7,271.20",
          "chgp": "23.24%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "15.10",
          "val2": "6.50",
          "chgp": "132.31%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "173.60",
          "val2": "108.60",
          "chgp": "59.85%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "7,717.00",
          "val2": "6,337.00",
          "chgp": "21.78%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "255.10%",
          "val2": "230.30%",
          "chgp": "2.48%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'26 - QoQ

Jun'26

Mar'26

Change(%)

Net Sales

7,315.00

8,140.60

-10.14%

Operating Profit (PBDIT) excl Other Income

1,865.30

2,763.60

-32.50%

Interest

2.60

0.40

550.00%

Exceptional Items

714.20

129.10

453.21%

Consolidate Net Profit

2,184.30

2,281.00

-4.24%

Operating Profit Margin (Excl OI)

218.40%

306.60%

-8.82%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Jun 2026 is -10.14% vs -3.56% in Mar 2026

Consolidated Net Profit

QoQ Growth in quarter ended Jun 2026 is -4.24% vs 16.57% in Mar 2026

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

31,431.00

27,787.80

13.11%

Operating Profit (PBDIT) excl Other Income

8,961.00

7,271.20

23.24%

Interest

15.10

6.50

132.31%

Exceptional Items

173.60

108.60

59.85%

Consolidate Net Profit

7,717.00

6,337.00

21.78%

Operating Profit Margin (Excl OI)

255.10%

230.30%

2.48%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 13.11% vs 22.70% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 21.78% vs 48.14% in Dec 2024

All Annual Results